Test for COVID-19 and Get Results in Minutes
The iHealth COVID-19 Antigen Rapid Test is a simple way to detect SARS-CoV-2 nucleocapsid protein antigen. It only requires four steps to complete the test, and all the materials needed to complete the test come in the box. Results are available in just 15 minutes. Because it is available without a prescription, you don’t need to visit a doctor’s office or lab. The test is packaged with two tests per box.
Contact us for bulk pricing.
Test for COVID-19 in 4 Easy Steps
Step 1: Swab
Brush against the inner wall of both nostrils 5 times each in a circular motion with a non-invasive nasal swab. Our nasal swab is soft, highly absorbent, and only needs to be inserted ½ – ¾ inches so you can test yourself comfortably.
Step 2: Dip
Insert the swab with the sample into the bottom of the tube and stir it in the fluid 15 times. Squeeze the sides of the tube around the swab as you pull it out.
Step 3: Drip
Put 3 drops of the mixed solution onto the sample port of the COVID-19 test card.
Step 4: Results
Start the timer. Your results
will be ready in 15 minutes.
About the iHealth COVID-19 Antigen Rapid Test
The iHealth® COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset.
This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.
Frequently Asked Questions
Have a question that is not answered here?
Email us at [email protected] or chat live with our customer service team Monday to Friday 9am to 6pm Pacific Time.
The iHealth® COVID-19 Antigen Rapid Test is an antigen test that works by detecting SARS-CoV-2, which is the virus that causes COVID-19. The test is also able to detect N protein or antigens, which are small parts of the virus., in your nasal secretions.
For details on how to perform the test, watch the instructional video here.
The iHealth® COVID-19 Antigen Rapid Test has been tested on several heat-inactivated variants of the COVID-19 virus and was able to detect the mutations. While the clinical performance has not been established in all circulating variants, it is expected to be reflective of the prevalent strains in circulation at the time and location of the clinical evaluation. Performance at the time of testing may vary depending on the variants circulating, which change over time.
There are two types of diagnostic tests used to detect an active COVID-19 infection: molecular tests and antigen tests.
Molecular tests, also known as PCR tests, detect genetic material from the virus that causes COVID-19.
Antigen tests detect proteins from the virus. While antigen tests are very specific for the virus, they are not as sensitive as molecular tests. As a result, a positive result is highly accurate, but a negative result doesn’t rule out infection.
Antibody tests, on the other hand, are not used to detect active infection. These tests detect the antibodies made by the immune system in response to a previous COVID-19 infection or vaccination.
No, the iHealth COVID-19 Antigen Rapid Test is not yet approved or cleared by the United States FDA. It is currently available under an emergency use authorization (FDA)
When Health and Human Services (HHS) declares a public health emergency, as they did for the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) may need to expedite the processes that determine if a drug, device, or test is safe and effective before authorizing it for use. After accounting for the risks associated with not making a product available, the agency may issue an Emergency Use Authorization (EUA). An EUA allows the FDA to expedite the authorization process for the use of medical products during a declared emergency. It’s important to note that an EUA is not equivalent to FDA clearance or approval. It is also temporary, lasting only until the declaration is terminated or revoked.
If you are within the service area, you can receive your order in as little as one hour.
If you are outside the service area, your order’s arrival date will depend on the carrier you select at checkout.
Once your order ships, you will receive a confirmation email with tracking. We will also send you an email once your order is delivered.
The iHealth COVID-19 Antigen Rapid Test is authorized for home use with self-collected anterior nasal swab specimens from individuals 15 years and older or with adult-collected anterior nasal swab samples from individuals 2 years or older.
In addition to being FDA-authorized for to test individuals within the first 7 days of symptom onset, the iHealth® COVID-19 Antigen Rapid Home Test is also authorized for serial testing.
Serial testing is when a single person is tested for COVID-19 more than once over the course of one to two days. Serial testing may be useful with antigen tests because they are less sensitive than other tests and false negatives are more likely to occur. Testing twice increases the chance the test will identify a positive case.
No. Currently, this test cannot be accepted as proof of a negative COVID-19 test for travel.
Yes. If you are asymptomatic, you will need to perform the test twice over two or three days with 24 to 48 hours in between tests.